These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4199238)

  • 41. Comparative study of the immunobiological properties of live brucellosis vaccines.
    Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI
    Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of a Brucella protein-polysaccharide antigen for the allergen diagnosis of brucellosis].
    Dzhasybaeva TS; SUkhodoeva GS; Vershilova PA; Dranovskaia EA; Kasymova KhA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):83-6. PubMed ID: 3929503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis of bovine brucellosis by means of a skin test with a polysaccharide allergen from Brucella abortus. I. Report: determination of the dose].
    BURKI F; MARGADANT C; MOSIMANN W
    Schweiz Z Pathol Bakteriol; 1955; 18(5):1147-56. PubMed ID: 13311483
    [No Abstract]   [Full Text] [Related]  

  • 44. [Physico-chemical properties of microbial antigens and the immuno-allergic tests].
    Beklemishev ND; Sukhodoeva GS; Bul'vakhter IaL; Shin NG
    Biull Eksp Biol Med; 1978 Mar; 85(3):322-5. PubMed ID: 96888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Detection of the antigens of the causative agent of brucellosis by an immunoenzyme method].
    Umnova NS; Zheludkov MM; Pavlova IP; Shakhanina KL
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):103-7. PubMed ID: 2446451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [T- and B-lymphocytes and an analysis of the specific reactivity in experimental brucellosis].
    Sukhodoeva GS; Nugmanova DS; Studentsova VK
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Feb; (2):69-73. PubMed ID: 84458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.
    Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S
    J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antigenic and immunologic interrelationships between brucellae and the agents of tularemia].
    Parnas Iu
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):60-2. PubMed ID: 4979510
    [No Abstract]   [Full Text] [Related]  

  • 49. Induced sensitization of normal laboratory animals to Brucella abortus endotoxin.
    Freedman HH; Fox AE; Willis RS; Schwartz BS
    J Bacteriol; 1968 Feb; 95(2):286-90. PubMed ID: 4966540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current advances in the biochemistry and biological properties of Brucella antigens].
    Dubray G
    Dev Biol Stand; 1984; 56():131-50. PubMed ID: 6436090
    [No Abstract]   [Full Text] [Related]  

  • 51. [Biological control of the brucellin INRA in sensitized guinea pigs: a guide for the statistical analysis of results].
    de Reviers M; Fensterbank R
    Ann Rech Vet; 1984; 15(3):395-403. PubMed ID: 6517480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
    Woodard LF; Toone NM; Jasman RL
    Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological titres following vaccination of sheep and goats with Brucella melitensis rev I vaccine.
    Worthington RW; Mülders MS; McFarlane IS; Becker D
    Onderstepoort J Vet Res; 1973 Mar; 40(1):1-5. PubMed ID: 4197921
    [No Abstract]   [Full Text] [Related]  

  • 54. The rapid adjuvant effect in the acquisition of delayed hypersensitivity to low molecular weight sensitizers in the guinea pig.
    Maguire HC; Coghlan P
    Int Arch Allergy Appl Immunol; 1971; 41(5):679-88. PubMed ID: 5163551
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunization against Brucella with killed vaccines. II. Immunizing activity of killed Brucella vaccines in guinea pigs.
    Rasooly G; Olitzki AL; Sulitzeanu D
    Isr J Med Sci; 1967; 3(6):814-21. PubMed ID: 4968077
    [No Abstract]   [Full Text] [Related]  

  • 56. Properties of an immunogenic fraction from Brucella abortus 45/20.
    Corbel MJ; Redwood DW
    Dev Biol Stand; 1984; 56():159-68. PubMed ID: 6436092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [ACTION EXERCISED BY BRUCELLA SUIS ON EXPERIMENTAL ALLERGIZATION BY MEANS OF HORSE SERUM].
    TURCANU AG; MARINOV I
    Arch Roum Pathol Exp Microbiol; 1963; 22():1023-30. PubMed ID: 14166967
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of two challenge strains used to test the potency of Brucella abortus vaccines.
    García-Carrillo C; Casas-Olascoaga R
    Br Vet J; 1977; 133(6):554-8. PubMed ID: 415793
    [No Abstract]   [Full Text] [Related]  

  • 59. Lymphocyte transformation and macrophage migration in guinea-pigs immunized with Freund's complete adjuvant.
    Ricci M; Romagnani S; Passaleva A; Biliotti G
    Clin Exp Immunol; 1969 Dec; 5(6):659-67. PubMed ID: 5365820
    [No Abstract]   [Full Text] [Related]  

  • 60. [Level of agglutinating and complement fixing antibodies in guinea pigs infected by uro-genital route with Brucella abortus].
    Sacco T
    Arch Vet Ital; 1968 Dec; 19(6):455-64. PubMed ID: 4979893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.